---
layout: page
title: "Our team"
permalink: /team/
---

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/test.jpg?raw=true" alt="Albert Ko" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Albert Ko</p>
    <p style="font-size: 18px; margin: 0;">Principal investigator</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Bio here
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/muenker-catherine.jpeg?raw=true" alt="Catherine Muenker" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Catherine Muenker</p>
    <p style="font-size: 18px; margin: 0;">Lab manager</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Catherine Muenker is a seasoned molecular biologist with over 25 years of experience in both academic and industry settings. She specializes in molecular biology techniques, including PCR, serology assays, cell culture, and bioimaging, with a particular focus on infectious diseases as the lab manager in the Ko Laboratory for the past 8 years. Catherine has contributed to numerous high-impact research projects, managed biorepositories, and conducted animal studies. Her expertise in research and development, combined with her dedication to mentoring and training, has made her a respected figure in the EMD Department.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/cavalcante-monique.jpeg?raw=true" alt="Monique Cavalcante" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Monique Cavalcante</p>
    <p style="font-size: 18px; margin: 0;">Project administrator (Fiocruz)</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Monique holds a degree in Business Administration specializing in Finance (2006), a Master’s in Regional and Urban Development from Universidade Salvador (2018), and a Public Health MBA (2023). Since 2008, she has been involved in managing research projects focused on the development of diagnostic tests and vaccines for Leptospirosis, cohort studies on children with congenital Zika virus syndrome, and a cohort project for the diagnosis of COVID-19 at the Laboratory of Pathology and Molecular Biology at the Gonçalo Moniz Institute, Fiocruz-BA. Outside of work, she enjoys traveling.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/nyathi-sindiso.jpg?raw=true" alt="Sindiso Nyathi" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Sindiso Nyathi</p>
    <p style="font-size: 18px; margin: 0;">Post-doctoral research associate</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Sindiso is a current Post-doctoral Research Associate with the Ko Lab. His research focuses on the molecular epidemiology and evolution of SARS-CoV-2. His broader research interests include global health, infectious disease modeling, molecular epidemiology and health policy, focused on Low and Middle Income Countries. Sindiso is interested in working to leverage the range of genomic, statistical and computational tools available today to improve public health and combat disease in LMICs. Outside of the lab he enjoys reading fantasy and sci-fi novels, hiking and backpacking, and running and swimming.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/aguilar-pablo.jpg?raw=true" alt="Juan Pablo Aguilar" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Juan Pablo Aguilar Ticona</p>
    <p style="font-size: 18px; margin: 0;">Post-doctoral research associate</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Juan P. Aguilar Ticona is a postdoctoral researcher at the Gonçalo Moniz Research Center, Fiocruz Bahia, where he is analyzing the antibody landscape of SARS-CoV-2 in a population with high hybrid immunity. He earned his medical degree from the Universidad Mayor de San Andrés (UMSA) in Bolivia. In 2015, he moved to Brazil as a postgraduate fellow funded by CAPES and CNPq, completing his doctorate in Public Health at the Federal University of Bahia (UFBA). During his doctoral studies, he conducted part of his research at the Yale School of Public Health under Professor Albert Ko, with whom he continues to collaborate on studies related to leptospirosis and arboviruses in the Pau da Lima cohort in Salvador, Brazil.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/nery-nivison.png?raw=true" alt="Nivison Nery" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Nivison Nery Junior</p>
    <p style="font-size: 18px; margin: 0;">Post-doctoral research associate</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Nivison Nery Jr. is a postdoctoral researcher at the Instituto Gonçalo Moniz (Fiocruz) in Bahia, Brazil. He completed his PhD in Public Health at Universidad Federal da Bahia. His research interests span various infectious diseases in Brazil, including Zika, chikungunya, dengue, and leptospirosis. He  is responsible for the information security and database management of the Leptospirosis and Dengue research group at Fiocruz-Bahia. Outside of the lab, he enjoys supporting his football club, Esporte Club Bahia.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/ribeiro-gabriel.jpg?raw=true" alt="Gabriel Ribeiro dos Santos" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Gabriel Ribeiro dos Santos</p>
    <p style="font-size: 18px; margin: 0;">Post-doctoral research associate</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Gabriel Ribeiro dos Santos is a mathematical modeller focusing on arboviral diseases and associated public health interventions. He joined the group in February 2024 as a Postdoctoral Associate and is currently a visiting scientist at the Instituto Gonçalo Moniz (Fiocruz) in Salvador, Brazil. He is developing methods to better capture the spatiotemporal dynamics of chikungunya transmission in order to inform future vaccination campaigns. He does so by applying Bayesian inference frameworks to serological and epidemiological data. He is also interested in investigating the impact novel vector-control technologies such as the release of Wolbachia-infected mosquitoes.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/cruz-jaqueline.jpg?raw=true" alt="Jaqueline Cruz" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Jaqueline Cruz</p>
    <p style="font-size: 18px; margin: 0;">Post-doctoral research associate</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Jaqueline Cruz is a pharmacist and postdoctoral researcher at the Gonçalo Moniz Institute (Fiocruz), Bahia, Brazil. In collaboration with Professors Albert Ko and Mitermayer Reis, she has been involved in research related to neglected tropical diseases, including leptospirosis, Zika, dengue, chikungunya, and COVID-19, using a One Health approach through serological and molecular biology techniques. Her recent research employs multiplex assays (Meso Scale Discovery) to investigate interactions between immune responses. Additionally, she participates in a wastewater surveillance project that monitors SARS-CoV-2 and other pathogens in vulnerable communities in Salvador, Bahia.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/khosavanna-ruchira.jpeg?raw=true" alt="Ruchira (Ruth) Khosavanna" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Ruchira (Ruth) Khosavanna</p>
    <p style="font-size: 18px; margin: 0;">Fellow</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Ruchira (Ruth) Khosavanna is an Infectious Disease fellow at Yale School of Medicine, Investigator track. Originally from Bangkok, Thailand, she moved to the US during undergraduate education, and eventually earned her medical degree from Oregon Health & Science University (OHSU). She completed Internal Medicine Residency, Global Health/Health Equity Track, from University of Florida - Shands hospital, Gainesville. Currently, her work focuses on surveillance of dengue and Zika among a cohort in Kamphaeng Phet, Thailand. Outside of her professional pursuits, she enjoys traveling, exploring new cuisines, and learning new languages.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/bi-sheng.png?raw=true" alt="Sheng Bi" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Sheng Bi</p>
    <p style="font-size: 18px; margin: 0;">Fellow</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Sheng Bi is an attending physician in the Infectious Diseases Department at the First Affiliated Hospital of Zhejiang University, School of Medicine. He holds an M.D. degree in Clinical Internal Medicine from Zhejiang University. Since 2015, he has been working at the First Affiliated Hospital of Zhejiang University, specializing in infectious diseases and internal medicine. In addition to his clinical role, he has also served as a clinical teacher, primarily responsible for the training of clinical clerks, interns, and international medical students. His main research areas include the epidemiology of tuberculosis and nontuberculous mycobacteria, as well as antimicrobial resistance. From September 2023 to December 2024, he is participating in the Global Health Leadership Development Program and has joined Professor Albert Ko's team to work on epidemiologic research of leptospirosis at Fiocruz Bahia and Yale.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/nelson-elisabeth.jpg?raw=true" alt="Elisabeth Zoe Nelson" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Elisabeth (Zoë) Nelson</p>
    <p style="font-size: 18px; margin: 0;">PhD student</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Elisabeth Nelson is a third-year Epidemiology of Microbial Diseases PhD student. She graduated from Georgetown University with a BS in the Biology of Global Health and the London School of Hygiene and Tropical Medicine with a MSc in the Control of Infectious Diseases. She is interested in novel forms of vector control and in optimizing Wolbachia release programs to help with scale-up and expansion in low-resource arboviral-endemic settings. She is currently working on a Wolbachia release randomized control trial in Belo Horizonte, Brazil. Outside of the lab, she enjoys skiing, yoga, and true crime, among other things.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/shang-lianhan.png?raw=true" alt="Lianhan Shang" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Lianhan Shang</p>
    <p style="font-size: 18px; margin: 0;">PhD student</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Lianhan is a second year PhD student in the Ko lab. He is now studying the protection effects of previous immune responses against COVID-19 infection and hospitalization. Outside of work, he's an enthusiastic badminton player and an aspiring chef. His culinary skills are currently at a solid 1% mastery level, but he's determined to improve - one wok at a time.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/carcamo-paloma.JPG?raw=true" alt="Paloma Carcamo" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Paloma Cárcamo</p>
    <p style="font-size: 18px; margin: 0;">PhD student</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Paloma is an Epidemiology of Microbial Diseases PhD student. She earned her MD from Universidad Peruana Cayetano Heredia, after which she worked as a research fellow at the Alexander von Humboldt Tropical Medicine Institute. She is currently working on optimizing Wolbachia-based interventions for arboviral disease risk reduction. In her free time, she enjoys looking at birds.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/satyanarayanan-karthika.jpeg?raw=true" alt="Karthika Satyanarayanan" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Karthika Satyanarayanan</p>
    <p style="font-size: 18px; margin: 0;">MPH student</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Karthika M. Satyanarayanan is a second-year Master of Public Health student at the Yale School of Public Health, specializing in infectious disease epidemiology. She earned her undergraduate degree in biology from Krea University, India. She joined Dr. Albert Ko's lab as a laboratory assistant in 2023 and worked as a research assistant during the summer of 2024, where she conducted data analysis to evaluate oviposition traps as a potential alternative to BG-Sentinel traps for monitoring Wolbachia prevalence in Rio de Janeiro. She will continue this research during the academic year. Outside the lab, Karthika enjoys drawing, reading, and rewatching Lord of the Rings.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/salazar-sebastian.png?raw=true" alt="Sebastian Salazar" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Sebastian Salazar</p>
    <p style="font-size: 18px; margin: 0;">MPH student</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Sebastian Salazar is a Master of Public Health candidate at the Yale School of Public Health, specializing in the epidemiology of microbial diseases. He holds an undergraduate degree in biology and chemistry from the University of New Mexico. With extensive experience as a first responder in Albuquerque’s emergency medical services, his passions lie in battlefield medicine, tactical combat casualty care, and combat medicine. Currently, his research focuses on how animal ownership impacts the risk of leptospirosis infection. Sebastian is also deeply committed to global health, particularly concerning neglected tropical diseases like leptospirosis and dengue in urban settings. Outside of his academic pursuits, he is an active competitor in soccer and basketball leagues and trains daily for triathlons.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/borrego-juan.jpeg?raw=true" alt="Juan Borrego" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Juan Borrego</p>
    <p style="font-size: 18px; margin: 0;">Undergraduate student</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Juan Borrego is an undergraduate student at Yale University and is currently researching how infrastructural factors are associated with dengue fever incidence in Rio de Janeiro, Brazil. As an aspiring physician and a passionate advocate for public health, he is deeply committed to bridging the gap between epidemiology and medicine to address health inequities and enhance community welfare. Outside of class, he serves as an EMT for Yale EMS and a Patient Navigator at the HAVEN Free Clinic. Dedicated to civic engagement, he also engages with New Haven public schools as a Community Health Educator.
    </p>
  </div>
</div>

<div style="display: flex; align-items: flex-start; margin-bottom: 20px;">
  <img src="https://github.com/ko-laboratory/site/blob/main/photos/delima-mark.jpeg?raw=true" alt="Mark DeLima" style="width: 150px; height: auto; margin-right: 20px; margin-top: 20px;">
  <div>
    <p style="font-size: 24px; margin: 0;">Mark DeLima</p>
    <p style="font-size: 18px; margin: 0;">Undergraduate student</p>
    <p style="font-size: 14px; margin-top: 5px;">
    Mark DeLima is a pre-med senior at Southern Connecticut State University, pursuing a degree in chemistry with a concentration in biochemistry. His current work involves conducting Meso Scale Discovery (MSD) assays on samples collected at Yale New Haven Hospital. This research contributes to an ongoing study on the correlates of protection for COVID-19, leading to a deeper understanding of the virus. In addition to his research, Mark assists the lab manager with various projects, such as databasing and updating the biorepository. He is passionate about applying his skills and knowledge to the medical field, with aspirations to make significant contributions to healthcare in the future.
    </p>
  </div>
</div>